CHATSWORTH, Calif. & NEW YORK--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ: IRIS) President and Chief Executive Officer César Garcia, along with Chief Technology Officer Dr. Thomas H. Adams and Iris Diagnostics President Thomas Warekois, told analysts and other select members of the investment community at a luncheon meeting today in New York that the Company has initiated and is actively engaged in the execution of its five-year plan, encompassing new platform technologies and strategic initiatives designed to complement its already established and growing core urinalysis business, with release of new products that will result in a minimum tripling of revenues in five years.
